Uncovering the metabolic underpinnings of T cell exhaustion
Uncovering the metabolic underpinnings of T cell exhaustion
批准号:
10593593
负责人:
Greg M. Delgoffe
金额:
$63.36万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-19 至 2027-07-31
关键词:
Acetyl Coenzyme AAconitate HydrataseAntigensAntioxidantsBiologyBlocking AntibodiesCell physiologyCellsCellular biologyCharacteristicsChronicCitratesCitric Acid CycleCysteineCytosolDataEnvironmentExposure toFatty AcidsFunctional disorderGenesGeneticGenetic TranscriptionGlucoseHypoxiaImmuneImmunityImmunosuppressionImmunotherapyIn VitroKnockout MiceLipidsLipolysisMalignant NeoplasmsMediatingMetabolicMetabolic stressMetabolismMitochondriaModalityModelingMonoclonal AntibodiesNutrientObesityOxidative StressOxygenPD-1 blockadePathway interactionsPatientsPeroxidesPharmacologyPhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotyrosinePlayProductionProtein Tyrosine PhosphataseProteomeProteomicsReactive Oxygen SpeciesRegulatory T-LymphocyteReportingRoleSignal TransductionSourceStressT cell differentiationT-LymphocyteTechnologyTissuesTumor ImmunityTumor-infiltrating immune cellsTyrosineUp-RegulationWeightanti-canceranti-tumor immune responsebiological adaptation to stressconditional knockoutcytokinecytotoxiccytotoxicitydesignexhaustexhaustionfatty acid oxidationimprovedin vivoinhibitorlipid biosynthesismembermitochondrial dysfunctionneoplastic cellnovelnovel therapeuticsoverexpressionpatient subsetspreventprogenitorprogrammed cell death protein 1responseself-renewalstress reactivitysuccesstranscriptomicstumor growthuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The successes of immunotherapies like blockade of co-inhibitory `checkpoint' molecules have changed the
treatment paradigm of cancer. However, the fact that robust responses are restricted to a subset of patients
highlights the need to further understand the biology of exhausted T cells: what drives their differentiation,
maintains their dysfunction, and how they may be reinvigorated to eradicate tumor cells. Our lab and others
have revealed that metabolic stress and mitochondrial dysfunction are key drivers in T cell exhaustion, both
from a cell extrinsic and cell intrinsic perspective. We recently reported that mitochondrial stress and reactive
oxygen species (ROS) production, driven to intolerable levels under hypoxic environments in the face of
persistent antigen, was sufficient to deviate cells into a terminally exhausted fate. Antioxidants both
pharmacologic and genetic could bias T cell differentiation away from exhaustion to more functional fates. But precisely how ROS production alters T cell fate and function remains unclear. One of the more intriguing
observations was elevating ROS via mitochondrial dysfunction altered T cell signaling: as peroxide is one of
the more potent inhibitors of tyrosine phosphatases, elevating ROS alone mimicked TCR and other
phosphotyrosine signals. ROS also dramatically reprograms cellular metabolism: by inhibiting aconitase, citrate is driven from the mitochondria where it is converted to acetyl-CoA, acting as a substrate for de novo
lipogenesis. As a result, while exhausted cells possess dysfunctional mitochondria and compete poorly for
glucose, they are loaded with lipid droplets and repress fatty acid oxidiation and lipolysis. While we know that
mitochondrial stress can drive T cells to exhaustion and that terminally exhausted T cells are metabolically
insufficient, the mechanisms that ultimately drive and enforce the phenotype remain unclear. In this Proposal,
we will identify the metabolic underpinnings of T cell exhaustion: how metabolic stress can interfere with
signaling, transcription, and differentiation. AIM 1: Determine how oxidative stress alters T cell signaling
cascades at the level of phosphatase inhibition. ROS play central roles in signaling as inhibitors of tyrosine
phosphatases. We will determine the role of ROS in exhausted T cell function in vivo, and use proteomics and
transcriptomic technologies to identify the phosphorylation cascades susceptible to ROS induction. AIM 2:
Identify how ROS-mediated changes in metabolic flux undermine T cell function. In this Aim, we will explore
the role increased lipid storage plays in T cell function and ask whether these elevated levels of lipids
represent `dead weight' or an untapped fuel source. AIM 3: Define the importance of altered nutrient pathways induced through oxidative stress responses. Our data suggest Slc16a11 similarly supports lactate uptake into exhausted T cells and maintains their dysfunctional state. Using a conditional knockout mouse and blocking antibodies, we will determine the importance of monocarboxylate metabolism in exhausted T cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the role of hypoxia in T cell differentiation in cancer
-
批准号:10578000
-
项目类别:
-
资助金额:$61.45万
-
财政年份:2023
-
负责人:Greg M. Delgoffe
-
依托单位:
Metabolic control of regulatory T cell functional identity
-
批准号:10510537
-
项目类别:
-
资助金额:$60.25万
-
财政年份:2022
-
负责人:Greg M. Delgoffe
-
依托单位:
Uncovering the metabolic underpinnings of T cell exhaustion
-
批准号:10707255
-
项目类别:
-
资助金额:$64.04万
-
财政年份:2022
-
负责人:Greg M. Delgoffe
-
依托单位:
Metabolic control of regulatory T cell functional identity
-
批准号:10677731
-
项目类别:
-
资助金额:$60.25万
-
财政年份:2022
-
负责人:Greg M. Delgoffe
-
依托单位:
Exploring and exploiting metabolic plasticity in regulatory T cells
-
批准号:9348845
-
项目类别:
-
资助金额:$230.11万
-
财政年份:2017
-
负责人:Greg M. Delgoffe
-
依托单位:
Elucidating the regulation of interleukin-35, a regulatory cytokine, in T cells
-
批准号:8255282
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2012
-
负责人:Greg M. Delgoffe
-
依托单位:
Elucidating the regulation of interleukin-35, a regulatory cytokine, in T cells
-
批准号:8610875
-
项目类别:
-
资助金额:$1.97万
-
财政年份:2012
-
负责人:Greg M. Delgoffe
-
依托单位:
Elucidating the regulation of interleukin-35, a regulatory cytokine, in T cells
-
批准号:8432601
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2012
-
负责人:Greg M. Delgoffe
-
依托单位:
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)
-
批准号:10331957
-
项目类别:
-
资助金额:$31.71万
-
财政年份:2004
-
负责人:Greg M. Delgoffe
-
依托单位:
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)
-
批准号:10704505
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2004
-
负责人:Greg M. Delgoffe
-
依托单位: